Polypharmacy Program Member Demographics
► The assessment is a high-level, general characterization of the Polypharmacy Program members who met the criteria.
► This description of members and/or dependents taking multiple medications does not include an assessment of specific health conditions, severity, comorbidities, or particular diagnoses.
► This evaluation does not assess treatment patterns preceding or following a hospitalization or ER event.
► Causality cannot be inferred from the current assessment.
► This characterization does not consider cost comparisons. 
Limitations of Current Evaluation

ER and Hospital Utilization
• Eligible patients were selected from Premera's pharmacy claims database.
• Both retail and mail-order pharmacy claims were used to identify eligible members.
• • WA (~91%), AK (~9%), AZ (<1%)
• For descriptive purposes only, pharmacy claims were grouped into mean monthly prescription-count categories to illustrate the distribution of claims.
• Roughly 10-20% in each of seven categories • Range: <=4 Rx per month to >9 Rx per month
• A one-year descriptive analysis of ER visits and hospitalizations indicates an increasing trend for both types of safety events as the average number of monthly prescriptions increased.
• Unadjusted logistic regressions (using a continuous mean monthly prescription variable) indicated an 12% and a 14% higher odds of having an ER visit and hospitalization, respectively, for a person prescribed one additional medication across the range.
• ER unadjusted OR (95% CI): 1.116 (1.098, 1.133)
• Hosp unadjusted OR (95% CI): 1.139 (1.118, 1.160)
• Logistic regressions adjusted for age and gender were consistent in demonstrating the main effect of increased numbers of prescriptions relating to statistically significantly higher odds of safety events, 13% and 14%, respectively for ER and hospitalization.
• ►We will further evaluate confounding factors related to the more severe health status of a population taking multiple medications (e.g., comorbidities).
►We are in the process of more comprehensively assessing this polypharmacy population by evaluating their pharmacy and medical claims and the associated costs. ►Our next step is to investigate the effects of the safety-focused mailing intervention by assessing claims using a 1-year pre-intervention and 1-year post-intervention approach.
Prescription-Count Category Percent By
Number of Monthly Pharmacy Claims (claims assessed for 1-year) Persons taking several medications simultaneously may be at increased risk for adverse safety events. 1 Research has shown that those taking numerous medications have a higher likelihood of emergency room (ER) visits and hospitalizations. 2,3,4 Providers, public and private insurers, and society as a whole have incentives to evaluate and better understand the implications of taking multiple prescriptions. 5 Premera Blue Cross, a not-for-profit health plan based in the state of Washington, instituted an education program for their polypharmacy members as a quality of care initiative for addressing safety-related issues in this population. The goal of the Polypharmacy Program is to promote medication reviews between patients and physicians, and to minimize prescription-related safety problems. The program involves selecting polypharmacy members who meet the eligibility criteria described below. These members receive an educational packet in the mail which includes:
Probability of ER and Hospitalization Events By Prescription-Count Category
• a "brown bag", for carrying their medications to their physician, • a blank medication list for listing current medications, and • a safety-related information brochure.
